Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  

Category Archives: Business, Finances, Insurance & Regulatory

You are here:
  1. Home
  2. News
  3. Category "Business, Finances, Insurance & Regulatory"

COVID Patient Support Program Extension: Free Medication from Bristol Myer Squibb (BMS)

Below is the letter we received with the details for this remarkable COVID inspired program. It contains links to a...
January 27, 2021Business, Finances, Insurance & Regulatory, C19 - Updates, NewsBy Brad Hedrick

NCCN Recommends Zanubrutinib as First-Line, Second-Line Therapy in CLL/SLL

NCCN Recommends Zanubrutinib as First-Line, Second-Line Therapy in CLL/SLL...
January 4, 2021Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick

Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients...
November 25, 2020Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick

Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia

Calquence (acalabrutinib) is a 2nd generation BTK inhibitor with a different side effect profile than ibrutinib. It is already approved...
November 13, 2020Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick

NICE okays chemotherapy-free combination venetoclax plus obinutuzumab for all front-line patients with chronic lymphocytic leukaemia (CLL)

NICE gives green light for chemotherapy-free combination of venetoclax plus obinutuzumab for all front-line patients with CLL ...
November 13, 2020Business, Finances, Insurance & Regulatory, NewsBy Brad Hedrick

The LLS CLL Co-Pay Assistance Fund is Open!

LLS may be able to help pay your insurance premiums and co-pays if you are in active treatment or are...
October 30, 2020Business, Finances, Insurance & RegulatoryBy Brad Hedrick

FDA Grants Fast Track Designation to Ublituximab Plus Umbralisib in Chronic Lymphocytic Leukemia

With this fast track designation, the combination of ublituximab and umbralisib should move through the FDA's approval process more quickly,...
October 27, 2020Business, Finances, Insurance & RegulatoryBy Brad Hedrick

New approval for venetoclax for Acute Myeloid Leukemia (AML)

The U.S. Food and Drug Administration (FDA) has granted full approval of venetoclax in combination with azacitidine, or decitabine, or...
August 20, 2020Business, Finances, Insurance & RegulatoryBy Brad Hedrick

FDA Clearance for clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia (CLL)

This is good news for CLL patients as measurement for MRD (minimal or measurable residual disease) is increasingly being recognized...
August 11, 2020Business, Finances, Insurance & Regulatory, MRD & Disease MonitoringBy Brad Hedrick

Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma

Hopefully the next approval will be for CLL patients, but there is still much work to be done in clinical...
July 27, 2020Business, Finances, Insurance & Regulatory, CAR-TBy Brad Hedrick
12345…
67
8
Next page
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
2021 Industry Advisory Council

Copyright 2021 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





This site uses cookies: Find out more.